Endo Agrees To $7.5M Deal With La. AG Over Opioid Claims
Endo Pharmaceuticals on Tuesday announced it had reached a $7.5 million deal with the Louisiana attorney general to end all opioid claims in the state as the company continues to face...To view the full article, register now.
Already a subscriber? Click here to view full article